Hydrogenated fat diet intake during pregnancy and lactation modifies the PAI-1 gene expression in white adipose tissue of offspring in adult life

1476-511X-7-13 1476-511X Research Hydrogenated fat diet intake during pregnancy and lactation modifies the PAI-1 gene expression in white adipose tissue of offspring in adult life Pisani P Luciana lucianapisani@gmail.com Oller do Nascimento M Claudia claudia.oller@unifesp.br Bueno A Allain allain@pol.pt Biz Carolina carol@ecb.epm.br Albuquerque T Kelse kelse@ecb.epm.br Ribeiro B Eliane eliane.beraldi@unifesp.br Oyama M Lila lmoyama@unifesp.br

Department of Physiology, Division of Nutrition Physiology, São Paulo Federal University – UNIFESP, Rua Botucatu, Vila Clementino, São Paulo 04023-062, Brazil

Department of Bioscience, São Paulo Federal University – UNIFESP, v. Ana Costa, Santos, São Paulo 11060-001, Brazil

Lipids in Health and Disease 1476-511X 2008 7 1 13 http://www.lipidworld.com/content/7/1/13 18394153 10.1186/1476-511X-7-13 20 12 2007 04 4 2008 04 4 2008 2008 Pisani et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

We examine whether feeding pregnant and lactating rats hydrogenated fats rich in trans fatty acids modifies the plasma lipid profiles and the expression of adipokines involved with insulin resistance and cardiovascular disease in their 90-day-old offspring. Pregnant and lactating Wistar rats were fed with either a control diet (C group) or one enriched with hydrogenated vegetable fat (T group). Upon weaning, the male pups were sorted into four groups: CC, mothers were receiving C and pups were kept on C; CT, mothers were receiving C and pups were fed with T; TT, mothers were receiving T and pups were kept on T; TC, mothers were receiving T and pups were fed with C. Pups' food intake and body weight were quantified weekly and the pups were killed at day 90 of life by decapitation. Blood and carcass as well as retroperitoneal, epididymal, and subcutaneous white adipose tissues were collected. Food intake and body weight were lower in TC and TT, and metabolic efficiency was reduced in TT. Offspring of TT and TC rats had increased white adipose tissue PAI-1 gene expression. Insulin receptor was higher in TT than other groups. Ingestion of hydrogenated vegetable fat by the mother during gestation and lactation could promote deleterious consequences, even after the withdrawal of the causal factor.

Introduction

Nutritional conditions during gestation have a major role in the metabolic and hormonal interactions between the maternal body, placenta, and fetus. The fetus growth is influenced by the maternal nutritional condition. Fetal insulin and insulin growth factor (IGF) have major roles in the regulation of growth, and respond rapidly to changes in fetal nutrition 1.

During gestation, changes in the maternal metabolism occur in order to supply nutrition to the fetus. Lipids play a fundamental role in fetal development. Although lipids transfer through placenta is very limited, changes in dietary fatty acids can lead to implications in fetal and postnatal development 2.

Metabolic programming occurs during the period of intra-uterus development. Inadequate nutritional and environmental factors may modify the fetal metabolic programming which could be reflected as deleterious consequences in adulthood, such as predisposition to develop cardiovascular and metabolic diseases 345.

Albuquerque et al 6 suggest that the exposition to trans fatty acids (TFA) during gestation and lactation can have harmful consequences to the offspring in adulthood. The levels of TFA in maternal milk are directly correlated to the maternal diet during gestation and lactation 7.

The chronic ingestion of hydrogenated vegetable fat rich in TFA and saturated fatty acids modifies the serum lipid profile, increases the risk of cardiovascular diseases, and reduces insulin sensitivity, leading to type 2 diabetes 8910. Also, Ibrahim et al 10 demonstrated that treatment with TFA has a much greater effect in decreasing adipocyte insulin sensitivity than treatment with saturated fatty acids. This result was in part explained by a reduction of plasma membrane fluidity in the rats treated with TFA.

Increases in PAI-1 serum concentrations are related to insulin resistance 1112 and the incidence of cardiovascular diseases in obesity 13141516.

Several studies in the literature have reported decreased adiponectin serum levels in patients with insulin resistance and type 2 diabetes mellitus, obesity and heart disease 1718. It has been demonstrated that adiponectin reduces hepatic production of glucose and the concentration of triglycerides in the muscles, thus ameliorating insulin sensitivity 19.

On the other hand, only a few studies have described the effects of the ingestion of TFA during gestation and lactation on the metabolism of offspring in adulthood. In this study we investigated the effects on 90-day-old offspring of maternal ingestion of a diet enriched with partially hydrogenated vegetable oil, rich in TFA, from the beginning of gestation through lactation, with continued exposure after weaning until the 90th day of life. The effects of this diet were also studied when the offspring were exposed to this diet during gestation and lactation only, or just after weaning. Some parameters of the metabolism were analyzed, as well as the gene expression of adipokynes involved with insulin resistance and cardiovascular diseases.

Methods

Animals and treatments

The Experimental Research Committee of the São Paulo Federal University approved all procedures for the care of the animals used in this study. Rats were kept under controlled conditions of light (12:12 h light-dark cycle with lights on at 07:00) and temperature (24 ± 1°C). Three-month-old female Wistar rats were left overnight to mate, and copulation was verified the following morning by the presence of sperm in the vaginal smears. On the first day of gestation, rats were isolated in individual cages and randomly divided into two groups, receiving either a control diet (C) or a diet enriched with hydrogenated vegetable fat (T). The diets were maintained throughout gestation and lactation. On the day of delivery, considered as day zero of lactation, each mother was given eight male pups. On the 21st day of life the animals were weaned and the pups were divided in four groups: CC, mothers fed C diet and pups fed C diet; CT, mothers fed C diet and pups fed T diet; TT, mothers fed T diet and pups fed T diet; TC, mothers fed T diet and pups fed C diet.

Both diets were prepared according to the recommendations of the American Institute of Nutrition (AIN-93 G and M) 20, being similar in calories and lipid content. The source of lipids for the C diet was soybean oil, and the principal source for the T diet was partially hydrogenated vegetable fat, rich in TFA. The centesimal composition of the diets is presented in Table 1. The fatty acid profile of each diet, presented in Table 2, was analyzed in the Laboratory of Food Composition, Federal University of Rio de Janeiro (RJ, Brazil), using gas chromatography.

Table 1

Composition of the control diet and diet enriched with trans fatty acids according to AIN-93

Diet (g/100 g)

Ingredient

Control

Trans

Casein*

20 (14)

L-cystine^†

0.3 (0.18)

0.3

Cornstarch^†

62 (71.1)

Soybean oil^‡

8 (5)

Hydrogenated vegetable fat^$

Butylhydroquinone^†

0.0014 (0.0008)

Mineral mixture^§

3.5

Vitamin mixture^#

1.0

Cellulose^†

5.0

Choline bitartrate^†

0.25

Energy (kcal/g)

4.0 (3.8)

The first number refers to the growth diet (AIN-93G) and the number in parentheses refers to maintenance diet (AIN-93M) when its composition differed from that of the growth diet. *Casein was obtained from CoperLab, São Paulo, Brazil. ^†L-cystine, cornstarch, butylhydroquinone, cellulose and choline bitartrate were obtained from Viafarma, São Paulo, Brazil. ^‡Oil was supplied from soybean (Lisa/Ind. Brazil). ^$Hydrogenated vegetabke fat was supplied from Unilever, São Paulo, Brazil. ^£Mineral mix 9mg/kg diet): calcium, 5000; phosphorus, 1561; potassium, 3600; sodium, 1019; chloride, 1571; sulfur, 300; magnesium, 507; iron, 35; copper, 6.0; manganese, 10.0; zinc, 30.0; chromium, 1.0; iodine 0.2; selenium, 0.15; fluoride, 1.00; boron, 0.50; molybdenum, 0.15; silicon, 5.0; nickel, 0.5; lithium, 0.1; vanadium, 0.1 (AIN-93G mineral mix DYETS 210025, Dyets Inc., Bethlehem, PA, USA). ^#Vitamin mix (mg/kg diet): thiamin HCL, 6.0, riboflavin, 6.0; pyridoxine HCL 7.0; niacin, 30.0; calcium pantothenate, 16.0; folic acid, 2.0; biotin, 0.2; vitamin B12, 25.0; vitamin A palmitate 4000 IU; vitamin E acetate, 75; vitamin D3, 1000 IU; vitamin KI, 0.75. (AIN-93G, vitamin mix, DYETS 310025, Dyets Inc., Bethlehem, PA, USA)

Table 2

Fatty acid composition of the diets

Percentage of total fatty acids

Fatty acid

Control

Trans

C14:0

0.60

0.85

C16:0

12.88

15.70

C18:0

3.88

13.77

C14:1

0.49

0.60

C18:1 n-9 trans

11.62

C18:1 n-9 cis

22.45

24.15

C18:2 n-6 trans

0.43

C18:2 n-6 (linoleic)

52.90

24.59

C18:3 n-3(α-linolenic)

5.41

1.51

Total SFA

17.36

30.32

Total MUFA-cis

22.94

24.75

Total PUFA-cis

58.31

26.10

Total TFA

12.05

PUFA:SFA

3.35

0.86

n-6:n-3

9.78

16.28

SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; ND, not detected, TFA, trans fatty acids.

Fatty acid composition of the diet

For lipid extraction, saponification, and fatty acid methylation, 500 mg of the prepared diets were treated with 2.0 ml of methanol:benzene (4:1, v/v) followed by 200 μl of acetyl chloride under light agitation. Fatty acid methyl esters were separated (SP2560 column, Supelco, Bellefonte, PA, USA) and quantified by gas-liquid chromatography with an ionizable flame detector (Perkin, Wellesley, MA, USA) and hydrogen as the carrier gas. Injection and detection temperatures were 260°C and 280°C, respectively. The run temperature started at 135°C and increased up to 195°C, with a run time of 45 minutes, as described by Albuquerque et al 6.

Experimental procedures

The offspring were weighed weekly from days 21 to 90 of life, when they were killed by decapitation. Trunk blood was collected and immediately centrifuged. Serum was separated and stored at -70°C for later determination of triglycerides, cholesterol, HDL-cholesterol, glucose, insulin, adiponectin, and leptin. The retroperitoneal (RET), epididymal (EPI) and subcutaneous (SUB) white adipose tissues were partially dissected, immediately frozen in liquid nitrogen, stored at -70°C, and used for quantification of adiponectin and PAI-1 mRNA. Leftover fat depots were immediately immerged in adequate buffer for total protein extraction, to allow quantification of insulin receptor.

Carcass lipid and protein content

A further group of CC, CT, TC, and TT rats was used for the determination of the carcass lipid and protein content. Carcasses were eviscerated, weighed, and stored at -20°C. Lipid content was measured as described by Stansbie et al 21 and standardized using the method described by Oller do Nascimento and Williamson 22. Briefly, the eviscerated carcass was autoclaved at 120°C for 90 minutes and homogenized with double the mass of water. Triplicate aliquots of this homogenate were weighed and digested in 3 ml of 30% KOH and 3 ml of ethanol for at least 2 hours at 70°C in capped tubes. After cooling, 2 ml of 12N H₂SO₄were added and the sample was washed three times with petroleum ether for lipid extraction. Results are expressed as grams of lipid per 100 g of carcass. For protein measurements, aliquots of the same homogenate (approximately 1 g) were heated to 37°C for 1 hour in 0.6N KOH with constant shaking. After clarification by centrifugation, protein content was measured according to the method described by Lowry et al 23.

RNA extraction and Northern blot analysis

Total RNA was extracted with Tri-Reagent (Sigma), and its concentration was determined from absorbance at 260 nm.

Adiponectin mRNA from RET was quantified by Northern blot analysis, using an antisense oligonucleotide (5'-GTTGCAGTGGAATTTGCCAGTGCCGTCA-3) based on the rat adiponectin cDNA sequence (PubMed), synthesized as a hybridization probe and end-labeled (5'-end) with a digoxigenin ligand (MWG, USA), as described by Trayhurn et al 24.

Twenty-microgram aliquots of RNA were run in 1% agarose-formaldehyde gel at 80–100 V, blotted overnight onto a positively charged nylon membrane (Roche), cross-linked under UV light, pre-hybridized with hybridization buffer (5 × SSC, 50 mM sodium phosphate, 2% blocking reagent, 0.1% N-lauroylsarcosine, 7% SDS, all from Sigma), and hybridized overnight at 42°C with the same buffer with an added rat adiponectin probe at a 25 ng/ml final concentration. Following post-hybridization washes, membranes were incubated with an antibody against digoxigenin (Fab-fragment; Roche) for 30 minutes and then with CDP-Star chemiluminescence substrate (Roche) for 10 minutes at room temperature. Signals were collected by exposure to film for 5–30 minutes at room temperature. After probing for adiponectin mRNA, blots were stripped and re-probed for 18S rRNA. The sequence of the antisense oligonucleotide 18S rRNA was described previously 25. Blots were quantified by densitometry using Image J software. Results are presented as the mRNA/18S rRNA ratio and expressed as arbitrary units.

Real-time polymerase chain reaction

PAI-1 mRNA from RET and EPI was quantified by real-time polymerase chain reaction (PCR). RNA samples were previously treated with DNAse (DNA-free, Ambion, UK). One microgram of each sample was reverse transcribed using an M-MLV Reverse Transcriptase kit (Promega), and cDNA was synthesized in a final volume of 50 μl. The relative level of PAI-1 mRNA was quantified in real time, using a SYBR Green primer in an ABI Prism 7700 Sequence Detector (both from Applied Biosystems). The relative level of the housekeeping gene hypoxanthine phosphoribosyltransferase (HPRT) was measured. The primers used were: PAI-1, 5'ACAGCCTTTGTCATCTCAGCC3' (sense) and 5'CCGAACCACAAAGAGAAAGGA3' (antisense); and HPRT, 5'CTCATGGACTGATTATGGACAGGA3' (sense) and 5'GCAGGTCAGCAAAGAACTTATAGC3' (antisense).

Results were obtained using Sequence Detector software (Applied Biosystems) and are expressed as a relative increase, using the method of 2^-ΔΔCtdescribed by Livak and Schmittgen 26.

Quantification of insulin receptor by Western blotting

Samples of EPI and SUB were rapidly dissected and homogenized in 1 ml of chilled extraction buffer (100 mM Trizma Base pH 7.5; 10 mM EDTA; 100 mM NaF; 10 mM Na₄P₂O₇; 10 mM Na₃VO₄; 2 mM PMSF; 0.1 mg/ml aprotinin). After homogenization, 100 μl of 10% Triton X-100 was added to the samples, which were left in ice for 30 minutes and then centrifuged (12,000 rpm, 20 minutes, 4°C). From each sample, 80 μg of protein in a 20 μl volume were loaded into a polyacrylamide gel containing 0.1% SDS, separated by electrophoresis, and then electroblotted onto a nitrocellulose membrane. Membranes were incubated with rabbit anti-rat primary antibody against insulin receptor (SC-711), followed by washings and incubation with goat anti-rabbit IgG-horseradish peroxidase (Sigma, USA). The labeled protein was detected by the chemiluminescent substrate ECL (Amersham) and exposed to Hyper-film ECL (Amersham). The protein bands were identified according to their migration in comparison to the rainbow recombinant protein molecular weight markers and quantified by densitometry using Image J software. Membranes were treated with specific buffers to remove previously linked antibodies, incubated with anti-β actin, and measured again. Results are expressed as arbitrary units, relative to β-actin values.

Biochemical and hormonal serum analysis

Glucose, triglycerides, total cholesterol, and HDL-cholesterol serum concentrations were measured by an enzymatic colorimetric method using commercial kits (Labtest, Brazil). Insulin, adiponectin, and leptin concentrations were quantified using specific enzyme-linked immunosorbent assay (ELISA) kits (Linco Research, USA).

Statistical analysis

All results are presented as means ± standard error of the mean (SE). Statistical significances of the differences between the means of the four groups of samples were assessed using one-way analysis of variance (ANOVA), followed by the Tukey's test. Differences were considered to be significant when p < 0.05.

Results

The body weights of the pups at 21 days old did not differ between the C and T groups. However, both the group TC at the seventh week and the group TT at the fourth week after weaning (Figure 1A) had lower body weights compared with CC. The total body weight gain in CC was higher than TT, TC and CT (Figure 1B). Also, TT had increase in total body weight gain as compared to TC group (Figure 1B). However, the food intake of both TT and TC was lower than CC and CT (Figure 1C).

Figure 1

(A) Body weight

(A) Body weight. (B) Total body weight gain. (C) Total food intake. (D) metabolic efficiency. CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, mothers fed T diet and offspring fed C diet. The number of studied animals per each group is 10. Data are means ± SE of 10 determinations per group. *p < 0.05, TT compared with CC. ^#p < 0.05, TC compared with CC.

The metabolic efficiency was higher in the TT group in relation to the other groups: for each gram of body weight gained, the TT ingested around 2.5 g of diet, whereas the other groups ingested around 3.2 g of diet (Figure 1D). The food intake of groups TC and TT was lower than CC (Table 3).

Table 3

Food intake (in grams per week)

Week

1^a

67.3 ± 3.1^a

58.3 ± 2.8^ab

64.7 ± 3.0^a

49.9 ± 1.4^b

2^a

108.3 ± 3.2^a

91.7 ± 5.8^a

72.9 ± 4.7^b

94.3 ± 1.8^a

3^a

127.12 ± 5.4^a

119.8 ± 5.2^a

91.7 ± 5.9^b

75.5 ± 4.1^b

4^a

158.4 ± 6.0^a

120.3 ± 9.1^b

100.3 ± 4.5^b

101.6 ± 4.5^b

5^a

141.5 ± 5.71^a

129.1 ± 6.9^ab

113.0 ± 3.5^bc

100.5 ± 3.8^c

6^a

153.9 ± 6.3^a

132.8 ± 6.2^ab

117.0 ± 5.1^b

123.3 ± 5.4^b

7^a

145.1 ± 6.7^a

141.0 ± 6.1^a

96.57 ± 4.2^b

137.3 ± 6.3^a

8^a

140.7 ± 4.3^ac

117.1 ± 7.5^ab

108.6 ± 4.7^b

141.5 ± 6.1^c

CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, mothers fed T diet and offspring fed C diet. Data are means ± SE of 10 determinations per group. p < 0.05. Values in the same line with different superscript letters are significantly different from one another at P < 0.05.

The exposure to TFA after weaning (namely CT and TT groups) caused an approximate 40% increase in the body fat content (Figure 2A), however, the other corporal parameters measured (body protein content, RET and EPI relative weight) were no different among the groups (Figure 2).

Figure 2

(A) Carcass fat content

(A) Carcass fat content. (B) Carcass protein content. (C) RET weight. (D) EPI weight. CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, mothers fed T diet and offspring fed C diet. Data are means ± SE of 10 determinations per group. p < 0.05.

Glycemia, lipid profile and leptin blood levels were similar among the studied groups. However, adiponectin blood levels were increased in TT (by 69%) and TC (by 34%) groups and insulinemia was higher in TT (by 84%) compared with the control group (Table 4).

Table 4

Serum glucose, triglycerides, total cholesterol, HDL-cholesterol, leptin, adiponectin and insulin

Glucose (mg/dl)

118.7 ± 4.7^a

98.8 ± 6.3^a

108.4 ± 2.0^a

101.8 ± 2.0^a

Triglycerides (mg/dl)

125.0 ± 13.5^a

126.0 ± 15.8^a

166.5 ± 11.6^a

147.9 ± 12.2^a

Cholesterol (mg/dl)

106.6 ± 11.5^a

110.5 ± 9.5^a

107.9 ± 8.4^a

125.9 ± 5.8^a

HDL-cholesterol (mg/dl)

55.2 ± 6.3^a

62.4 ± 5.7^a

53.4 ± 3.9^a

66.0 ± 6.0^a

Cholesterol/HDL-cholesterol

1.9 ± 0.05^a

1.8 ± 0.04^a

2.0 ± 0.1^a

Leptin (ng/ml)

10.10 ± 0.77^a

8.80 ± 0.67^a

9.23 ± 1.01^a

7.18 ± 1.46^a

Adiponectin (μg/ml)

51.33 ± 4.71^a

51.23 ± 4.32^a

86.53 ± 3.79^b

68.60 ± 6.37^c

Insulin (ng/ml)

1.23 ± 0.20^a

1.95 ± 0.39^b

2.26 ± 0.25^b

1.80 ± 0.34^ab

Adiponectin gene expression in RET of the CT group was higher than in the CC group (Figure 3). On the other hand, a decrease was observed in PAI-1 gene expression in the CT group (Fig 4A) compared with the other groups.

Figure 3

Adiponectin mRNA quantification in retroperitoneal white adipose tissue

Adiponectin mRNA quantification in retroperitoneal white adipose tissue. CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, mothers fed T diet and offspring fed C diet. Data are means ± SE of six determinations per group. Results are expressed in arbitrary units, stipulating 100 as the control value. p < 0.05.

Figure 4

PAI-1 mRNA quantification in (A) retroperitoneal and (B) epididymal white adipose tissues

PAI-1 mRNA quantification in (A) retroperitoneal and (B) epididymal white adipose tissues. CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, mothers fed T diet and offspring fed C diet. Data are means ± SE of six determinations per group. Results are expressed in arbitrary units, stipulating 100 as the control value. p < 0.05.

PAI-1 gene expression in EPI was increased in the TT and TC groups (215% and 175% higher, respectively) compared with the CC and CT groups (Figure 4B). In this tissue, a higher protein level of insulin receptor (IR) was found in the CT compared with the CC and TT groups (Figure 5A).

Figure 5

Quantification of insulin receptor in (A) epididymal and (B) subcutaneous white adipose tissues

Quantification of insulin receptor in (A) epididymal and (B) subcutaneous white adipose tissues. CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, mothers fed T diet and offspring fed C diet. Data are means ± SE of six determinations per group. Results are expressed in arbitrary units, stipulating 1 as the control value. p < 0.05.

Thus, treatment with the T diet from gestation to the end of the period studied (group TT) caused an increase in IR protein levels in SUB (Figure 5B).

Discussion

In this study, the effects of maternal ingestion of hydrogenated vegetable fat rich in TFA, during gestation and lactation, followed by continued exposure of the offspring to this diet after weaning until the 90th day of life were investigated. We have also analyzed the effects of exposure to this diet just after weaning.

The food intake of the TC and TT groups was lower than the CC group, demonstrating that the ingestion of TFA by the mother during gestation and lactation can affect the feeding behavior of the offspring from 21 to 90 days of life.

Albuquerque et al 6 suggested that early exposure to TFA promoted adaptations in the hypothalamic mechanisms controlling food intake, and that these adaptations probably became programmed.

Wang et al 27 verified that the treatment with a high-fat diet rich in n-6 polyunsaturated fatty acids (PUFA) increased the gene expression of neuropeptide Y (NPY) in the arcuate nucleus of mice, as compared with mice treated with a high-fat diet rich in saturated fatty acids.

Since, the T diet contained TFA and saturated fatty acids and a low amount of n-3 and n-6 PUFA, in comparison with the control diet, it is possible to suggest that the TC and TT groups present low production of NPY and, as a consequence, hypophagia in relation to the control group. Likewise, Albuquerque et al 6 verified that the maternal ingestion of TFA reduced the concentrations of arachidonic acid, docosahexaenoic acid and total PUFA content in the total lipids of the brain obtained from 21-day-old offspring.

The ingestion of TFA reduced body weight gain. However, the TT group had the highest metabolic efficiency. These results suggest that the treatment, from fetal life until adulthood, with a diet rich in TFA and saturated fatty acids can reduce energy expenditure. Supporting this suggestion, Takeuchi et al 28 demonstrated that diet-induced thermogenesis is high in rats treated with a PUFA-rich diet compared with a diet rich in saturated fatty acids.

The carcass lipid content in the CT and TT groups was higher than in the CC group. Similar findings were described by Takeuchi et al 28 in animals treated with a diet rich in saturated fatty acids. Furthermore, Shillabeer and Lau 29 demonstrated that diets rich in saturated fatty acids promote the replication of adipocytes. It is possible that this mechanism contributed to the high carcass lipid content found in the CT and TT groups.

In a previous study, our group detected a dyslipidemia in the 21-day-old offspring of mothers treated with TFA 30, although the lipid profile was similar among groups in the 90-day-old rats used in the present study. Gutman et al 31 reported that the increased plasma triglyceride levels caused by the ingestion of high amounts of sucrose is multiphasic and depends on the period of treatment. This treatment was found to increase triglyceridemia progressively until the 22nd to 25th day of treatment, reduces to normal levels at the 45th to 50th day, and increases again at the 75th to 90th day of treatment. In this sense, it was demonstrated that rats fed with diets rich in TFA and saturated fatty acids for 12 weeks presented with increase serum insulin, triglyceride, and cholesterol levels 10. These findings support our results and thus we cannot rule out the possibility that metabolic processes adapt to changes in the dietary components in a specific period of life.

Furthermore, a high adiponectin serum level was found in the TT and TC groups, which could be considered as a normal lipid profile, since it was described previously that adiponectin stimulates fatty acid oxidation and adiponectin serum level negatively correlates with triglyceride serum level 32.

The TT group had normoglycemia, increased insulin serum levels, and protein levels of IR in SUB. It has been shown that increased adiponectin levels are associated with a better glucose-level control in diabetics 33. It is therefore reasonable to suggest that the increased serum adiponectin level associated with hyperinsulinemia and IR protein levels could contribute to the maintenance of glucose serum levels in the TT group.

The increase in PAI-1 gene expression in adipocytes was associated with insulin resistance 34 and hyperinsulinaemia 35. This could partially explain the increases in PAI-1 mRNA (215%) in EPI of the TT group. However, we also found an increase in PAI-1 mRNA levels in EPI of the TC group compared with the CC group. Previously, we found high PAI-1 mRNA levels in 21-day-old offspring of rats fed a diet containing hydrogenated vegetable fat during gestation and lactation 30. These results suggested that early exposure to hydrogenated vegetable fat caused an alteration in adipose tissue PAI-1 gene expression and that this alteration became programmed. Enhanced expression of the PAI-1 gene in visceral fat correlates with increased plasma levels 36 and a positive correlation between PAI-1 levels and cardiovascular disease is well described in the literature 1137.

In summary, in this study we have found increased levels of insulin, adiponectin, body fat, and epididymal adipose tissue PAI-1 mRNA levels in 90-day-old offspring of rats fed a diet containing hydrogenated vegetable fat during gestation and lactation and exposed to the same diet after weaning (TT group). The trans offspring exposed to the control diet after weaning (TC group) also had an increase in adiponectin serum concentration and PAI-1 mRNA levels in EPI. These alterations were not observed in the CT group. It has been hypothesized that these conditions are produced by programming resulting from early exposure to dietary hydrogenated fat which could promote deleterious consequences, even after the withdrawal of the causal factor. TFA were probably important determinants of these alterations. However, it cannot be ruled out that differences in saturated and essential fatty acid contents between the control and the TFA diets played a role.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

LPP made substantial contributions to conception and design, experimental analysis and acquisition of data and also the analysis and interpretation of data. CMON participated in the design of the study and performed the statistical analysis and helped to draft the manuscript. AAB carried out the immunoassays and helped to draft the manuscript. CB participated in all molecular and biochemical analyses. KTA participated in the design of the study and in the insulin receptor analysis. EBR participated in the design of the study and performed the statistical analysis. LMO made substantial contributions to the conception and design, analysis and interpretation of the data and coordination to draft the manuscript. All authors read and approved the final manuscript.

Acknowledgements

This research was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo) and CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior). The authors grateful to Mauro Cardoso for the animal care.

<it>In utero </it>programming of chronic disease Barker DJP Clin Sci 1998 95 115 128 10.1042/CS19980019 9680492 Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development – a review Herrera E Placenta 2002 Suppl A S9 S19 10.1053/plac.2002.0771 Fetal programming and adult health Godfrey KM Barker DJ Public Health Nutr 2001 4 611 624 11683554 Fetal origins of adult disease? Morley R Dwyer T Clin Exp Pharmacol Physiol 2001 28 962 966 10.1046/j.1440-1681.2001.03557.x 11703406 Epidemiological challenges in studying the fetal origins of adult chronic disease Gillman MW Int J Epidemiol 2002 31 294 299 10.1093/ije/31.2.294 11980782 Intake of trans fatty acid-rich hydrogenated fat during pregnancy and lactation inhibits the hypophagic effect of central insulin in the adult offspring Albuquerque KT Sardinha FL Telles MM Watanabe RL Nascimento CM Tavares do Carmo MG Ribeiro EB Nutrition 2006 22 820 829 10.1016/j.nut.2006.04.009 16815496 Trans fatty acids in human milk in Poland and their association with breastfeeding mothers' diets Mojska H Socha P Socha J Soplinska E Jaroszewska-Balicka W Szponar L Acta Paediatr 2003 92 1381 1387 10.1080/08035250310006692 14971786 Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein Lichtenstein AH Erkkila AT Lamarche B Schwab US Jalbert SM Ausman LM Atherosclerosis 2003 171 97 107 10.1016/j.atherosclerosis.2003.07.005 14642411 Dietary fat intake and risk of type 2 diabetes in women Salmeron J Hu FB Manson JE Stampfer MJ Colditz GA Rimm EB Willett WC Am J Clin Nutr 2001 73 1019 1026 11382654 Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats Ibrahim A Natrajan S Ghafoorunissa R Metab Clin Exp 2005 54 240 246 15789505 Trombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus Juhan-Vague I Alessi MC Vague P Ann Med 1996 28 371 380 10.3109/07853899608999095 8862693 Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity Alessi MC Bastelica D Morange P Berthet B Leduc I Verdier M Geel O Juhan-Vague I Diabetes 2000 49 1374 1380 10.2337/diabetes.49.8.1374 10923640 Elevated expression of transforming growth factor-beta in adipose tissue from obese mice Samad F Yamamoto K Pandey M Loskutoff DJ Mol Med 1997 3 37 48 2230108 9132278 TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes Sakamoto T Woodcock-Mitchell J Marutsuka K Mitchell JJ Sobel BE Fujii S Am J Physiol 1999 276 C1391 C1397 10362602 Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes Birgel M Gottschling-Zeller H Rohrig K Hauner H Arterioscler Thromb Vasc Biol 2000 20 1682 1687 10845889 The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome – an analysis by structural equation modelling Chan JCN Cheung JCK Stehouwer CDA Emeis JJ Tong PCY Ko GTC Yudkin JS Int J Obes 2002 26 994 1008 10.1038/sj.ijo.0802017 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Hotta K Funahashi T Arita Y Takahashi M Matsuda M Okamoto Y Iwahashi H Kuriyama H Ouchi N Maeda K Nishida M Kihara S Sakai N Nakajima T Hasegawa K Muraguchi M Ohmoto Y Nakamura T Yamashita S Hanafusa T Matsuzawa Y Arterioscler Thromb Vasc Biol 2000 20 1595 1599 10845877 The role of the novel adipocyte-derived hormone adiponectin in human disease Diez JJ Iglesias P Eur J Endocrinol 2003 148 293 300 10.1530/eje.0.1480293 12611609 Adipose tissue as an endocrine organ Prins JB Best Pract Res Clin Endocrinol Metab 2002 16 639 651 10.1053/beem.2002.0222 12468412 Components of the AIN-93 diets as improvements in the AIN-76A diet Reeves PG J Nutr 1997 127 Suppl 838S 841S Regulation of pyruvate dehydrogenase and pyruvate dehydrogenase phosphate phosphatase activity in rat epididymal fat-pads. Effects of starvation, alloxan-diabetes and high-fat diet Stansbie D Denton RM Bridges BJ Pask HT Randle PJ Biochem J 1976 154 225 236 1172695 6018 Evidence for conservation of dietary lipid in the rat during lactation and the immediate period after removal of the litter Oller do Nascimento CM Williamson DH Biochem J 1986 239 233 236 1147266 3099779 Protein measurement with the Folin phenol reagent Lowry OH Rosebrough NJ Farr AL Randall RJ J Biol Chem 1951 193 265 275 14907713 Chemiluminescent detection of m RNAs on northern blots with digoxigenin end-labelled oligonucleotides Trayhurn P Duncan JS Nestor A Thomas ME Rayner DV Anal Biochem 1994 222 224 230 10.1006/abio.1994.1477 7856853 Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (oblob) mice Trayhurn P Thomas ME Duncan JS Rayner DV FEBS Lett 1995 368 488 490 10.1016/0014-5793(95)00719-P 7635205 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Livak KJ Schmittgen TD Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression Wang H Storlien LH Huang XF Am J Physiol Endocrinol Metab 2002 282 E1352 E1359 12006366 Diet-induced thermogenesis is lower in rats fed a lard diet than in those fed a high oleic acid safflower oil diet, a safflower oil diet or a linseed oil diet Takeuchi H Matsuo T Tokuyama K Shimomura Y Suzuki M J Nutr 1995 125 920 925 7722695 Regulation of new fat cell formation in rats: the role of dietary fats Shillabeer G Lau DC J Lipid Res 1994 35 592 600 8006514 Hydrogenated fat intake during pregnancy and lactation modifies serum lipid profile and adipokine mRNA in 21-day-old rats Pisani LP Oyama LM Bueno AA Biz C Albuquerque KT Ribeiro EB Oller do Nascimento CM Nutrition 2008 24 255 261 10.1016/j.nut.2007.12.001 18178060 Long-term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose-rich diet Gutman RA Basílico MZ Bernal CA Chicco A Lombardo YB Metabolism 1987 36 1013 1020 10.1016/0026-0495(87)90019-9 3670072 The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects Yu JG Javorschi S Hevener AL Kruszynska YT Norman RA Sinha M Olefsky JM Diabetes 2002 51 2968 2974 10.2337/diabetes.51.10.2968 12351435 Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes Mantzoros CS Li T Manson JE Meigs JB Hu FB J Clin Endocrinol Metab 2005 90 4542 4548 10.1210/jc.2005-0372 15914524 Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes Venugopal J Hanashiro K Yang ZZ Nagamine Y Proc Natl Acad Sci USA 2004 101 17120 17125 535371 15569940 10.1073/pnas.0405278101 Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes Harte AL McTernan PG McTernan CL Smith SA Barnett AH Kumar S Diabetes Obes Metab 2003 5 302 310 10.1046/j.1463-1326.2003.00276.x 12940867 Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Shimomura I Funahashi T Takahashi M Maeda K Kotani K Nakamura T Yamashita S Miura M Fukuda Y Takemura K Tokunaga K Matsuzawa Y Nat Med 1996 2 800 803 10.1038/nm0796-800 8673927 Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes Seki T Miyasu T Noguchi T Hamasaki A Sasaki R Ozawa Y Okukita K Declerck PJ Ariga T J Cell Physiol 2001 189 72 78 10.1002/jcp.1140 11573206